Drug intelligence / Profile preview

CF-M801

Development stage
Phase 1
Lead developer
CEFO
Modality
Stem Cell Therapies → Cell Therapies
Administration
Local Implantation (direct Intralesional Injection During Surgical Core Decompression)
01

Overview

CF-M801 is an investigational stem cell therapy consisting of human umbilical cord-derived osteoblasts (hUC-Os), which are osteogenic differentiation-induced cells from human umbilical cord mesenchymal stem cells (hUCMSCs). The therapy is being developed for the treatment of musculoskeletal conditions, specifically targeting joint preservation in diseases such as osteonecrosis of the femoral head (ONFH), osteoporotic fractures, and as an adjunct to spinal fusion. The mechanism involves transplantation of these differentiated cells into affected bone tissue, where they are expected to promote bone regeneration and repair through direct engraftment and paracrine effects. The developer and active organization for this product is CEFO Co., Ltd. Clinical development has reached Phase 1 trials in South Korea[1][8].

Beyond the preview

Go deeper on CF-M801.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CF-M801.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call